InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by AGENUS INC. Director active across 1 company, notably MiNK Therapeutics, Inc.. Aggregated, 2 reports have been published. Split: 2 buys · 0 sell. Total volume traded: €28.9m. Activity tracked since 19 October 2021. The latest transaction was disclosed on 19 October 2021 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
1,400,000 shares@ US$12.00100.0% of flowCommon StockSEC:0000899243-21-040873
Ideal exit: 16 Jul 2022 (T+270)
1,400,000 shares@ US$12.0027.04% mcap50.0% of flowCommon StockSEC:0000899243-21-040873:0
Ideal exit: 16 Jul 2022 (T+270)
2 of 2 declarations
